|
FLT3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.650600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.464200E-01 |
| Normal-vs-Stage2 |
5.982800E-01 |
| Normal-vs-Stage3 |
5.123600E-01 |
| Normal-vs-Stage4 |
7.523400E-01 |
| Stage1-vs-Stage2 |
3.898200E-01 |
| Stage1-vs-Stage3 |
8.948600E-01 |
| Stage1-vs-Stage4 |
9.461600E-01 |
| Stage2-vs-Stage3 |
3.729000E-01 |
| Stage2-vs-Stage4 |
4.720600E-01 |
| Stage3-vs-Stage4 |
8.919000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.707560E-01 |
| Normal-vs-AfricanAmerican |
4.460400E-02 |
| Normal-vs-Asian |
5.882000E-01 |
| Caucasian-vs-AfricanAmerican |
1.346240E-02 |
| Caucasian-vs-Asian |
4.266600E-01 |
| AfricanAmerican-vs-Asian |
2.940000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.368800E-01 |
| Normal-vs-Female |
5.257000E-01 |
| Male-vs-Female |
5.893600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.014800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.029200E-01 |
| Normal-vs-Age(61-80Yrs) |
9.380400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.486100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.177800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.130200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.615800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.056600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.551900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.928100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.359600E-01 |
| Normal-vs-Grade 2 |
6.801000E-01 |
| Normal-vs-Grade 3 |
9.635400E-01 |
| Normal-vs-Grade 4 |
3.234100E-02 |
| Grade 1-vs-Grade 2 |
3.301800E-01 |
| Grade 1-vs-Grade 3 |
5.885800E-01 |
| Grade 1-vs-Grade 4 |
1.070840E-01 |
| Grade 2-vs-Grade 3 |
6.012600E-01 |
| Grade 2-vs-Grade 4 |
1.334070E-02 |
| Grade 3-vs-Grade 4 |
1.550260E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.677200E-01 |
| Normal-vs-ccB subtype |
1.634610E-01 |
| ccA subtype-vs-ccB subtype |
2.622600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.186200E-01 |
| Normal-vs-N1 |
9.796000E-01 |
| N0-vs-N1 |
9.824800E-01 |
|
|
